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Results: Successful reperfusion was achieved with tailored
thrombolytic therapy in all patients. Only one patient had rein-
farction on the 3rd day, for which she received another half-dose
Tenectaplase. She remained asymptomatic subsequently. 2 pa-
tients had IV site ecchymosis; no patient had major bleeding. All
the patients had one month follow-up and were asymptomatic.
Conclusion: Tailored thrombolytic therapy in very elderly pa-
tients, many of whom also have high bleeding risk factors, is
effective as well as safe. With the increasing lifespan, the number
of very elderly patients with STEMI is going to increase in the
future, posing a challenge of bleeding risk vs benefit with reper-
fusion strategies; tailored thrombolytic therapy would have
greater relevance in the future and needs to be studied in larger
number of patients.
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Background: Inflammation has been widely acknowledged to
contribute throughout all stages of atherogenesis. At present none
of the anti-cytokine therapy has a specific place in standard
therapeutic regimen for management of CAD. The project aims at
controlling the low grade systemic inflammation in CAD using
Sulfasalazine to improve overall disease outcome.
Methods: 50 eligible subjects (M/F¼43/7) meeting the inclusion/
exclusion criteria for CAD and low grade systemic inflammation,
were randomly assigned to once daily drug (n¼25, mean age¼
57.33±1.52 years) or placebo (n¼25, mean age¼58.58+2.16 years)
tablets (500 mg) for six months along with the previously
continued treatment regimen in all subjects. Assessment was
carried out at baseline, 12 week and subsequently after 24 weeks
of treatment. Various measures like, (a) hsCRP (b) Endothelial-
dependent Flow Mediated dilatation (FMD) of the brachial artery,
(c) Carotid artery IMT and artery stiffness index (Young’ elastic
Modulus), d) Hb, TLC, DLC, SGOT & SGPT, and creatinine were
evaluated. Student’s t-test (p<0.05) was used.
Results: hsCRP declined to (1.12±0.07 vs. 2.40±0.20mg/l, p<0.01),
SBP (118.20±3.11 vs. -128.95±4.19 mmHg, p¼0.04), carotid IMT
(0.68±0.02 vs. 0.79±0.01 mm (p<0.01) and carotid stiffness to 9.73
±0.91 vs. 15.87±3.11 mmHg.mm (p¼0.06) from baseline in drug
group as compared to placebo group, respectively. FMD improved
to 18.31±1.52 vs. 11.72±1.36% in drug group as compared to pla-
cebo group, (p¼0.02), whereas endothelium-independent vasodi-
lation with nitroglycerin (17.76±0.1.27 vs. 17.91± 1.41%; p¼0.94)
remained unchanged in both the groups. Moreover, safety
markers were with-in the normal range in both the groups
(p>0.05).
Conclusions: Thus, it is concluded that Sulfasalazine may act as
novel adjuvant therapeutic approach along with other standard
therapies for the management of CAD due to its effectiveness in
improving the endothelial dysfunction, reducing inflammation
and carotid stiffness.
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Background: Cardiovascular disease is the leading cause of death
worldwide and a majority of these deaths are attributable to
Myocardial infarction. Due paramountcy was given to evaluate
the correlation between the acute phase reactants and the
severity of acute coronary syndrome. One marker which was
under great a deliberation for long was fibrinogen. Albeit thorough
research, the association was debated till recently when many of
the western studies showed a correlation. None of the studies
were done on Indian population.
Objective: To study the correlation between serum fibrinogen
level (SFL) and severity of ACS.
Methods: This is a prospective study on hospitalized patients with
ACS. ACS was diagnosed based on clinical presentation, ECG and
cardiac biomarkers. Blood for fibrinogen was drawn at admission
and was measured by chemiluminescence technique. Coronary
angiography was performed through the femoral artery access
and the angiograms were evaluated by interventional cardiolo-
gists who will be blinded to the study. The severity of ACS was
assessed by Gensini score. Data analysis and interpretation was
done with SPSS 20. The statistical significance of association was
assessed by chi square test and p value of less than 0.05 was
considered significant.
Results: We serially analysed 91 patients presenting with ACS
from February 2014 to April 2014. 29 patients were excluded as per
pre-specified criteria. SFL was plotted against Gensini score in the
remaining 62 patients. Pearson’s correlation coefficient between
SFL and Gensini score was r¼0.869. We have found a significant
correlation between SFL and Gensini score with a significant p
value (<0.05).
Conclusion: Statistically significant correlation exists between SFL
and Gensini score. Higher SFLwere associatedwith higher Gensini
score. We hence conclude to say that serum fibrinogen can be
used to assess the severity of ACS.
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Background: India has a large number of deaths occurring due to
premature CAD, resulting from major risk factors like deranged
lipids. Familial Hypercholesterolemia (FH) is characterized by
isolated high levels of total and LDL cholesterol. It is an autosomal
dominant trait and is highly under recognized entity which if
diagnosed and treated early can prevent deaths due to CAD.
Methods: We enrolled 85 subjects suspected of FH: high total and
LDL cholesterols (>95thcentile), family history of hypercholester-
olemia and premature CAD. Molecular analysis was carried out in
three candidate genes: LDLR, fragment of exon 26 and 29 of ApoB
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100 and PCSK9. Cascade screening was carried out in families with
confirmed mutations. Sanger sequencing was used for screening
point mutations and small insertions and deletions. For large
rearrangements dosage analysis was performed by MLPA
technique.
Results: Disease causing mutations were found in 32 families,
while analysis is still in progress for rest of the cases. All muta-
tions have been found in the LDLR gene. Five cases were homo-
zygous for the LDLR mutation. One mutation, c.1587-1 G>A in
intron 10 was found in four families which may represent a
founder mutation in Indians. Three mutations; p.S177L in exon 4,
c.2416_2417 insG; p. V806Gfs*11 in exon 17 and p. L654P in exon 16
were found in two families each. On cascade screening, 63 out of
120 (52%) familymemberswere found to harbor the family specific
mutation.
Conclusion: All FH confirmed cases were referred to the lipid/
cardiology clinics for lifestyle modifications and therapeutic in-
terventions. In cases with high cholesterols, genetic analysis
confirms the disorder and that all the first degree relatives are at
50% risk of developing premature CAD. The diagnosis based on
genetic studies is more sensitive and accurate than lipid analysis
alone for diagnosis of FH. Cascade screening was useful in diag-
nosing family members with FH who were unaware of their dis-
order.
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Background: The costs of caring for patients with coronary artery
disease (CAD) are enormous. The high rates of finding normal
coronaries at invasive angiography in individuals with suspected
CAD clearly indicates the need for devising tools to correctly
identify the patients with high probability of having obstructive
CAD especially severe disease. The following study was done to
identify the clinical and non invasive predictors of the presence
and extent of coronary artery disease.
Methods: The study was carried at a tertiary care hospital at
Shimla, Himachal Pradesh in the department of Cardiology over a
period of 1 year. All consecutive patients undergoing conventional
coronary angiography for suspected CAD were enrolled after
obtaining informed written consent.
Results: 335 individuals underwent angiography for suspected
CAD over a 1 year period. The mean age of the study population
was 55.47±9.44 years and 68.6% were males. 80.2% of subjects
had undergoing treadmill test in the 1 month preceding coronary
angiography. 25% had a carotid Doppler evaluation prior to cor-
onary angiography. 48.9% had evidence of coronary artery dis-
ease, 37.8% had single vessel disease, 30.4% had double vessel
disease, and 31.8% had three vessel disease. Left main coronary
artery disease was present in 5.4%. In multivariate analysis,
typical angina was the only independent predictor of the pres-
ence of coronary artery disease. Framingham risk score was an
independent predictor of multivessel disease and Duke Tread-
mill Score was an independent predictor of disease extent and
severity.
Conclusions: 51.2% of subjects undergoing coronary angiography
for suspected CAD had normal coronaries. Typical angina was the
only independent predictor of coronary artery disease on angi-
ography. Framingham risk score and duke treadmill score were
independent predictors of disease severity.
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Background: STEMI is a major cause of death in India. Data on
STEMI is scarce in the Indian population. This study determined
the characteristics, treatment and outcomes of STEMI in an Indian
sub-urban tertiary care Centre.
Methods: We carried out a prospective observational study of 709
consecutive STEMI patients hospitalized between January 2013
and December 2013 in Sri Venkateswara institute of medical sci-
ences, Tirupati. Patient characteristics, angiographic features,
complications and 30-day outcomes were determined.
Results: The mean age of patients was 54.02±11.57 years. Males
were 570(80.39%). Diabetes and hypertension were present in
223(31.45%) and 267(37.66%) respectively. 352(49.65%) were
smokers while 196 (27.64%) were alcoholics. 53(7.47%) had past
coronary artery disease (CAD) history and 8 (1.13%) had family
history of CAD. Only 166 (23.41%) used ambulance to come to
hospital while 50.9% used private vehicles and 3.94% used two
wheelers. 68(9.59%) patients had renal dysfunction. Mean ejection
fraction was 45.23±8.84%. AWMI, IWMI and PWMI were present in
61.55%, 38.10% and 0.35% respectively. Single vessel disease,
double vessel disease and triple vessel disease was present in
66.1%, 26.1% and 7.7 % respectively. Infarct related artery was
LAD, LCX and RCA in 287 (65.23%), 37 (8.41%) and 116 (26.36%).
GpIIb/ IIIa inhibitors were used in 227(32.01%). Angioplasty was
done in 508(71.65%) while 329 (64.76%) had DES and 179 (35.24%)
had BMS. Average stent length and stent diameter were
20.04±7.57 mm and 2.97±0.52 mm respectively. 115(27.1%) had
thrombolytic therapy, 284(40.05%) patients underwent primary
angioplasty and 399 (32.85%) presented out of window period.
Overall CABG rate was 12.2%. 30 day mortality was 4.93%
including 1.41% in primary angioplasty group and 6 had
reinfarction.
Conclusions: STEMI patients tend to be younger than in devel-
oped countries. Few patients utilized ambulance while most
used private transport. Coronary angiography and primary an-
gioplasty are being increasingly performed. Mortality was
comparable to developed countries. Increased use of evidence
based therapy, compared to CREATE registry. Mortality can be
further decreased by the use of emergency transport services,
public awareness and increased performance of primary
angioplasty.
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